Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 34534430

Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2022 Jan 20
First author
Li BT

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2021 Dec;18(12):748. doi: 10.1038/s41571-021-00569-y.
    note
    Source null
    related pmid
    34611335
    relationship
    Comment in
  2. citation
    N Engl J Med. 2022 Jan 20;386(3):286-289. doi: 10.1056/NEJMe2119442.
    note
    Source null
    related pmid
    35045232
    relationship
    Comment in
  3. citation
    N Engl J Med. 2022 May 5;386(18):1769-1770. doi: 10.1056/NEJMc2202305.
    note
    Source null
    related pmid
    35507494
    relationship
    Comment in
  4. citation
    N Engl J Med. 2022 May 5;386(18):1770. doi: 10.1056/NEJMc2202305.
    note
    Source null
    related pmid
    35507495
    relationship
    Comment in
  5. citation
    Am J Respir Crit Care Med. 2024 Mar 15;209(6):748-750. doi: 10.1164/rccm.202208-1596RR.
    note
    Source null
    related pmid
    38190703
    relationship
    Comment in

Authors and identifiers

  1. name
    Li BT
    type
    Author
  2. name
    Smit EF
    type
    Author
  3. name
    Goto Y
    type
    Author
  4. name
    Nakagawa K
    type
    Author
  5. name
    Udagawa H
    type
    Author
  6. name
    Mazières J
    type
    Author
  7. name
    Nagasaka M
    type
    Author
  8. name
    Bazhenova L
    type
    Author
  9. name
    Saltos AN
    type
    Author
  10. name
    Felip E
    type
    Author
  11. name
    Pacheco JM
    type
    Author
  12. name
    Pérol M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Li BT
    type
    Author
  2. name
    Smit EF
    type
    Author
  3. name
    Goto Y
    type
    Author
  4. name
    Nakagawa K
    type
    Author
  5. name
    Udagawa H
    type
    Author
  6. name
    Mazières J
    type
    Author
  7. name
    Nagasaka M
    type
    Author
  8. name
    Bazhenova L
    type
    Author
  9. name
    Saltos AN
    type
    Author
  10. name
    Felip E
    type
    Author
  11. name
    Pacheco JM
    type
    Author
  12. name
    Pérol M
    type
    Author
bibliography ids
  1. nci-bib-bc97e4004b5864923038c903
book metadata
content sha256
8c4e667728f250f6be96cd15a6001457816299f5042d09da08f1b2ad71600917
document type
citation
dois
  1. 10.1056/NEJMoa2112431
electronic publication date
display
2021 Sep 18
precision
day
year
2021
evidence scope
bibliographic_metadata_only
id
pubmed:34534430
immutable id
pubmed:34534430@8c4e667728f250f6be96cd15a6001457816299f5042d09da08f1b2ad71600917
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
3
name
The New England journal of medicine
nlm unique id
0255562
pages
241-251
volume
386
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2021 Dec;18(12):748. doi: 10.1038/s41571-021-00569-y.
    note
    Source null
    related pmid
    34611335
    relationship
    Comment in
  2. citation
    N Engl J Med. 2022 Jan 20;386(3):286-289. doi: 10.1056/NEJMe2119442.
    note
    Source null
    related pmid
    35045232
    relationship
    Comment in
  3. citation
    N Engl J Med. 2022 May 5;386(18):1769-1770. doi: 10.1056/NEJMc2202305.
    note
    Source null
    related pmid
    35507494
    relationship
    Comment in
  4. citation
    N Engl J Med. 2022 May 5;386(18):1770. doi: 10.1056/NEJMc2202305.
    note
    Source null
    related pmid
    35507495
    relationship
    Comment in
  5. citation
    Am J Respir Crit Care Med. 2024 Mar 15;209(6):748-750. doi: 10.1164/rccm.202208-1596RR.
    note
    Source null
    related pmid
    38190703
    relationship
    Comment in
outcomes validated
false
pmid
34534430
provenance
batch id
192b6392c165c6b06274
provider
NCBI PubMed ESummary
record sha256
234d3c50d8cce4f0f6b8f5aa80c418d6bd052275a156657eeed026c18d186ac2
response sha256
7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
retrieved at
2026-09-09T23:48:02.713075+00:00
publication date
display
2022 Jan 20
precision
day
year
2022
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/34534430/
title
Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer.

Preserved source evidence · Independent clinical review pending · Not medical advice